no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18–49 years to assess safety and preliminary observation of immunogenicity
|
Wu, Jin-Yuan |
|
|
42 |
19 |
p. 4030-4039 |
article |
2 |
COVID-19 vaccine acceptance and uptake among caregivers of children aged 5–11 years in Ontario, Canada: A cross-sectional survey
|
Karimi-Shahrbabak, Elahe |
|
|
42 |
19 |
p. 3974-3980 |
article |
3 |
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study
|
Kandasamy, Rama |
|
|
42 |
19 |
p. 4066-4071 |
article |
4 |
Editorial Board
|
|
|
|
42 |
19 |
p. ii |
article |
5 |
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024
|
Laniece Delaunay, Charlotte |
|
|
42 |
19 |
p. 3931-3937 |
article |
6 |
Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain
|
Jiménez-Sepúlveda, Natali |
|
|
42 |
19 |
p. 4011-4021 |
article |
7 |
Effectiveness of the varicella vaccine in the real world, a matched case-control study
|
Liu, Fang |
|
|
42 |
19 |
p. 3968-3973 |
article |
8 |
Evaluation of antibody responses in healthcare workers before & after meningococcal vaccine and determination of meningococcal carriage rates
|
Baskol Elik, Dilsah |
|
|
42 |
19 |
p. 3961-3967 |
article |
9 |
Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial
|
Muangnoicharoen, Sant |
|
|
42 |
19 |
p. 3999-4010 |
article |
10 |
HPV vaccine standing orders and communication in primary care: A qualitative study
|
Mansfield, Lisa N. |
|
|
42 |
19 |
p. 3981-3988 |
article |
11 |
Interchangeability of different COVID-19 vaccine platforms as booster doses: A phase 3 study mimicking real-world practice
|
Ann Costa Clemens, Sue |
|
|
42 |
19 |
p. 3989-3998 |
article |
12 |
Mixed methods examination of risk perception on vaccination intentions: The perspective of doctor–patient communication
|
Zhou, Haichun |
|
|
42 |
19 |
p. 4072-4080 |
article |
13 |
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010
|
Uraguchi, Kensuke |
|
|
42 |
19 |
p. 4081-4087 |
article |
14 |
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection
|
Lee, Keon Young |
|
|
42 |
19 |
p. 3953-3960 |
article |
15 |
Role of rotavirus vaccine in reducing diarrheal episodes in infants visiting private primary health care clinics in Karachi, Pakistan: A mixed-methods study
|
Karim, Sehrish |
|
|
42 |
19 |
p. 4022-4029 |
article |
16 |
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial
|
Le Gars, Mathieu |
|
|
42 |
19 |
p. 3938-3952 |
article |
17 |
Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.)
|
Griffin, Isabel |
|
|
42 |
19 |
p. 4056-4065 |
article |
18 |
Seroprotection against tetanus in the Italian general population
|
Bagordo, Francesco |
|
|
42 |
19 |
p. 4040-4045 |
article |
19 |
The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study
|
Kim, Sol |
|
|
42 |
19 |
p. 4046-4055 |
article |